<DOC>
	<DOCNO>NCT02132663</DOCNO>
	<brief_summary>This clinical trial evaluate investigational infant formula alternate source DHA determine provide normal growth well tolerated term infant compare marketed routine infant formula .</brief_summary>
	<brief_title>The Effects Growth Tolerance Routine Infant Formula Fed Term Infants</brief_title>
	<detailed_description />
	<criteria>Singleton , 1014 day age randomization Term infant birth weight minimum 2500 gram Solely formula feed Signed Informed Consent Protected Health Information History underlie metabolic chronic disease immunocompromised Feeding difficulty formula intolerance</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>